Similar articles

• [Timely screening routines for prostatic cancer by Norwegian physicians].

  Fosså SD, Eri LM. Fosså SD, et al. Tidsskr Nor Laegeforen. 1999 Oct 10;119(24):3572-6. Tidsskr Nor Laegeforen. 1999. PMID: 10563174 Norwegian.
• Editorial. PSA screening and low risk prostate cancer, what's going on? are we shooting the messenger?

  Martínez-Salamanca JI. Martínez-Salamanca JI. Arch Esp Urol. 2012 Mar;65(2):209-14. Arch Esp Urol. 2012. PMID: 22414449 English, Spanish. No abstract available.
• Prostate-specific antigen and screening for prostate cancer.

  Han M, Gann PH, Catalona WJ. Han M, et al. Med Clin North Am. 2004 Mar;88(2):245-65, ix. doi: 10.1016/S0025-7125(03)00188-3. Med Clin North Am. 2004. PMID: 15049577 Review.
• How important are the prostate-specific antigen assays?

  Vessella RL. Vessella RL. Contemp Intern Med. 1994 Feb;6(2):76-89. Contemp Intern Med. 1994. PMID: 10146682 No abstract available.
• [Use of prostate specific antigen. A review].

  Brasso K, Skaarup P, Roosen JU, Iverson P. Brasso K, et al. Ugeskr Laeger. 1998 Jul 27;160(31):4510-6. Ugeskr Laeger. 1998. PMID: 9700305 Review. Danish.